![Tesamorelin - 10MG [GHRH Analog (Entry-Point Research Vial)]](http://dazaenhanced.com/cdn/shop/files/TESA.png?v=1780280282&width=120)
Tesamorelin - 10MG [GHRH Analog (Entry-Point Research Vial)]
![Tesamorelin - 10MG [GHRH Analog (Entry-Point Research Vial)]](http://dazaenhanced.com/cdn/shop/files/TESA.png?v=1780280282&width=3840)
Tesamorelin - 10MG [GHRH Analog (Entry-Point Research Vial)]
GHRH Analog (Entry-Point Research Vial)
Tesamorelin (10mg) will be supplied in Australia with fast domestic shipping to all states and territories.
Tesamorelin is a stabilised analog of growth hormone-releasing hormone (GHRH). Research interest centres on its preferential effect on visceral adipose tissue (VAT) rather than general weight reduction — distinguishing it from GLP-1-class compounds. Mechanism: stimulated endogenous GH release with downstream IGF-1 elevation.
Key Research Areas
- Visceral Adipose Reduction — Studied specifically for reducing deep abdominal fat
- Body Recomposition — Research focused on fat distribution rather than gross weight change
- GH/IGF-1 Axis — Stimulates endogenous GH release with downstream IGF-1 effects
- Entry-Point Format — 5mg vial suitable for short preliminary research protocols
Supplied as lyophilized powder at high purity, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia.
⚠ For in-vitro research and laboratory use only. Not for human consumption.
⚠ For in-vitro research and laboratory use only. Not intended for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.
